Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- CNRS
- Nantes Université
- Université de Caen Normandie
- CEA
- Nature Careers
- Université Savoie Mont Blanc
- Université de Haute-Alsace
- Aix-Marseille Université
- European Magnetism Association EMA
- Inria, the French national research institute for the digital sciences
- Institut Pasteur
- UNIVERSITE PARIS CITE
- Université de Limoges
- Université de Strasbourg
- BRGM
- CNRS-ENS-UCBL
- Centre de Nanosciences et de Nanotechnologies
- Consortium Virome@tlas
- FRANCE ENERGIES MARINES
- Grenoble INP - Institute of Engineering
- IFP Energies nouvelles (IFPEN)
- INSERM
- INSERM U1183
- INSTITUT NATIONAL DES SCIENCES APPLIQUEES
- Le Mans Université
- Observatoire de la Côte d'Azur
- SORBONNE UNIVERSITE
- University of Lille
- Université Bourgogne Europe
- Université Grenoble Alpes
- Université Toulouse III Paul Sabatier
- Université de Reims Champagne Ardenne
- 22 more »
- « less
-
Field
-
. This will be made on different Cu-FR4-Cu laminate test-structures with a FR4 thickness ranging between 35 to 100 μm. A preliminary assembly process optimization will be performed (e.g., temperature
-
, funded by the Bourgogne-Franche-Comté Region and co-funded by HARMI as part of the “Structuration de la Recherche en Bourgogne-Franche-Comté” program, through the TRANSBIO Graduate School. Planned timeline
-
-free solvents. Thermodynamic modeling studies will be used to determine the choice of solvents. The structural properties and magnetization dynamics will be measured by ferromagnetic resonance. The final
-
increase in the number of strains that are multi-resistant to antifungal agents is leading to a growing incidence of two other species, C. glabrata and C. auris. Being a complex and dynamic structure
-
electronic structure on the ferroelectric properties. The chosen materials will be optimized by successive simulation, processing, and characterization iterations and integrated into scaled arrays to provide
-
, cellular, molecular, and structural approaches, focuses on generating and characterizing human monoclonal antibodies to viruses including HIV-1, Hepatitis E and B, as well as emerging pathogens such as SARS